GlassScriptPhysician profile
Brooke E Vanderby
NPI 1164654810
$4,597.49
in general payments reported to CMS, 2019-2025
18 companies · $288 in 2025
The $288 reported for 2025 was more than what 86% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $622 · 2021: $420 · 2022: $503 · 2023: $415 · 2024: $901 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,374.64 | 2019-2025 | Eterna, Proclaim, Ionicrf |
| Boston Scientific Corporation | $281.37 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Stratus Medical, LLC | $163.38 | 2023-2025 | Nimbus |
| Painteq LLC | $156.77 | 2024 | Painteq |
| Medtronic USA, INC. | $112.86 | 2019 | |
| Abbvie INC. | $93.55 | 2022-2023 | Botox |
| Amgen INC. | $84.10 | 2020 | |
| Spr Therapeutics, INC | $68.89 | 2024-2025 | Sprint Pns System |
| Horizon Therapeutics Plc | $60.89 | 2019-2020 | |
| Allergan, INC. | $33.11 | 2019-2022 | |
| Pacira Therapeutics, INC. | $28.89 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.80 | 2023 | Iovera, Zilretta |
| Curonix LLC | $23.43 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $21.74 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $19.18 | 2024 | Dysport |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $19.16 | 2020 | |
| Ferring Pharmaceuticals INC. | $18.86 | 2025 | Euflexxa |
| Mdd US Operations, LLC | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Vanderby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.